This publication aims to present different contributions to a workshop on challenges for pharmaceutical policies in the 21st century. The central theme was the impact of globalization, bringing together a representative set of academic researchers, policymakers, NGO and industry stakeholders. The debate in Europe is sensitive, since most European
health care systems are facing coming financing issues, with the growth of elderly (grey power) and "babyboomers" as representative elective force, increase of expensive
medical technologies and enlargement towards Central and
Southern Europe, facing poverty, organized crime and a high level of corruption in such a sector. The objective of such…
